PMID- 38162651 OWN - NLM STAT- MEDLINE DCOM- 20240103 LR - 20240329 IS - 1664-3224 (Electronic) IS - 1664-3224 (Linking) VI - 14 DP - 2023 TI - Causal relationship between asthma and ulcerative colitis and the mediating role of interleukin-18: a bidirectional Mendelian study and mediation analysis. PG - 1293511 LID - 10.3389/fimmu.2023.1293511 [doi] LID - 1293511 AB - OBJECTIVE: Numerous observational investigations have documented a correlation between asthma and ulcerative colitis(UC). In this Mendelian Randomization (MR) study, we utilized extensive summary data from Genome-Wide Association Studies (GWAS) to further estimate the association between adult-onset asthma and the risk of UC, and to investigate the role of Interleukin-18 (IL-18) as a potential mediator. MATERIALS AND METHODS: A two-step, two-sample MR study was conducted through mediation analysis. For this study, we employed a two-sample MR analysis using the inverse variance-weighted (IVW), weighted median, weighted mode, and MR-Egger regression techniques. We utilized publicly accessible summary statistics from a GWAS meta-analysis of adult-onset asthma in the UK Biobank (n=327,253; cases=26,582; controls=300,671) as the exposure factor. The outcomes were derived from GWAS data of individuals with European ancestry (n=26,405; cases=6,687; controls=19,718). GWAS data for IL-18 were obtained from individuals of European ancestry (n=9,785,222; cases=3,636; controls=9,781,586). RESULTS: The MR analysis indicates that adult-onset asthma is associated with an increased risk of UC, with an odds ratio (OR) of 1.019 (95% CI 1.001-1.045, P=0.006). However, there is no strong evidence to suggest that UC significantly impacts the risk of adult-onset asthma. IL-18 may act as a potential mediator in the causal relationship between adult-onset asthma and UC, with a mediation proportion of 3.9% (95% CI, 0.6%-6.9%). CONCLUSION: In summary, our study established a causal relationship between asthma and UC, in which IL-18 contributes to a small extent. However, the primary factors underlying the influence of asthma on UC remain unclear. Future research should focus on identifying other potential mediators. In clinical practice, it is important to pay greater attention to intestinal lesions in patients with asthma. CI - Copyright (c) 2023 Zou, Lu, Liao, Liu and Dai. FAU - Zou, Xin AU - Zou X AD - Department of Gastroenterology, Ganzhou Municipal Hospital(Guangdong Provincial People's Hospital Ganzhou Hospital), Ganzhou, Jiangxi, China. FAU - Lu, Rui-Ling AU - Lu RL AD - Department of Gastroenterology, Ganzhou Municipal Hospital(Guangdong Provincial People's Hospital Ganzhou Hospital), Ganzhou, Jiangxi, China. AD - Department of Rheumatology and Immunology, The Second Clinical Medical College, Jinan University (Shenzhen People's Hospital), Shenzhen, Guangdong, China. FAU - Liao, Bin AU - Liao B AD - Department of Gastroenterology, Ganzhou Municipal Hospital(Guangdong Provincial People's Hospital Ganzhou Hospital), Ganzhou, Jiangxi, China. FAU - Liu, Shi-Jie AU - Liu SJ AD - Department of Gastroenterology, Geriatric Center, National Regional Medical Center, Guangdong Provincial People's Hospital Ganzhou Hospital, Ganzhou, Jiangxi, China. FAU - Dai, Shi-Xue AU - Dai SX AD - Department of Gastroenterology, Geriatric Center, National Regional Medical Center, Guangdong Provincial People's Hospital Ganzhou Hospital, Ganzhou, Jiangxi, China. LA - eng PT - Journal Article DEP - 20231214 PL - Switzerland TA - Front Immunol JT - Frontiers in immunology JID - 101560960 RN - 0 (Interleukin-18) SB - IM MH - Adult MH - Humans MH - *Asthma/genetics MH - *Colitis, Ulcerative/genetics MH - Genome-Wide Association Study MH - *Interleukin-18/genetics MH - Mediation Analysis MH - Mendelian Randomization Analysis PMC - PMC10757619 OTO - NOTNLM OT - Mendelian randomization OT - asthma OT - causal inference OT - interleukin-18 OT - mediation OT - tool variables OT - ulcerative colitis COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2024/01/02 11:45 MHDA- 2024/01/03 09:44 PMCR- 2023/01/01 CRDT- 2024/01/01 04:27 PHST- 2023/09/13 00:00 [received] PHST- 2023/11/30 00:00 [accepted] PHST- 2024/01/03 09:44 [medline] PHST- 2024/01/02 11:45 [pubmed] PHST- 2024/01/01 04:27 [entrez] PHST- 2023/01/01 00:00 [pmc-release] AID - 10.3389/fimmu.2023.1293511 [doi] PST - epublish SO - Front Immunol. 2023 Dec 14;14:1293511. doi: 10.3389/fimmu.2023.1293511. eCollection 2023.